BIOPATTERN

BIOPATTERN is a groundbreaking project that integrates key elements of European research to underpin eHealth. The goal is to develop a pan-European, intelligent analysis of a citizen's bioprofile; to make the analysis of this bioprofile remotely accessible to patients and clinicians; and to exploit bioprofile to combat major diseases such as cancer and brain diseases.

Today, the ability to produce vast amounts of bio-data has vastly outstripped our ability to sensibly make use of the data for decision making.

A key objective of BIOPATTERN is to address the problem of fragmentation in this key area by bringing together key researchers to create a critical mass of specialists to promote the development of computational intelligence methods underpinning e-Healthcare. The idea is to move away from local solutions to local problems and towards European wide solutions to European problems.

The main objectives are:

  • Integration - to tackle and reduce fragmentation of existing research capacities in this area
  • Virtual Research Institute - to create a new research community
  • New opportunities - to identify how bioprofile could be exploited for healthcare, such as disease prevention, diagnosis and treatment
  • Roadmap - to identify gaps in knowledge, key challenges and to initiate joint activities to address them.
  • Standards - To identify technical and ethical issues on which guidelines and standards should be based with regard to the acquisition, transmission and analysis of a bioprofile
  • Societal challenges - To contribute to finding solutions to some of the demanding societal challenges in healthcare.

For further information, please visit:
http://www.biopattern.org

Project co-ordinator:
University of Plymouth

Partners:

  • University of Plymouth - Plymouth NHS Trust Hospitals - Aston University - University of Liverpool - University of Nottingham - Liverpool John Moores University - Nottingham Trent University - Sheffield Hallam University - BioElf Ltd - Gap Infomedia Ltd (UK)
  • Universita Degli Studi Di Firenze - Universita Degli Studi Di Pisa - Instituto Nazionale Per Lo Studio Cura Dei Tumori, Milano - Universita Degli Studi Di Milano - Synapsis S. R. L (IT)
  • University of Athens Medical School - Telecommunication Systems Institute - Technological Educational Institute of Crete - University of Crete, Medical Division - Aristotelio Panepistimio Thessalonikis - Hellenic Telecommunications & Telematics Applications Company SA (Forthnet) - Daedalus Informatics Ltd (GR)
  • Neoventor Medicinsk Innovation AB - University College Boras (SE)
  • Katholieke Universiteit Leuven Research & Development (BE)
  • Stichting Katholieke Universiteit (NL)
  • Instituto De Desenvolvimento De Novas Tecnologias - (UNINOVA) (PT)
  • Ecological University of Bucharest (FI)
  • University of Malta (MT)

Timetable: from 01/04 - 12/07

Total cost: € 12.800.000

EC funding: € 6.400.000

Instrument: NoE

Project Identifier: IST-2002-508803

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...